Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know - Yahoo Finance
19 hours ago • Google News
Crispr Therapeutics AG (CRSP)
US$ 37.531.46%
Price Chart
Key Statistics
Market Cap
$ 3.33B
P/E Ratio
0.00
Revenue (TTM)
$ 37.68M
Volume
1.29M
52W High
$ 67.88
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.74
Technicals
50-Day MA
36.8051
200-Day MA
43.3952
52 Week High
67.88
52 Week Low
30.04
About CRSP
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.
Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.
Latest News
CRSP Sees Significant Increase in Bullish Option Activity | CRSP Stock News - GuruFocus
Yesterday • Google News
Zacks Research Issues Optimistic Outlook for CRSP Earnings - MarketBeat
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg